Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$440K Buy
1,215
+6
+0.5% +$2.05K 0.05% 218
2026
Q1
$426K Sell
1,209
-19
-2% -$6.77K 0.06% 198
2025
Q4
$402K Buy
1,228
+160
+15% +$50.8K 0.06% 194
2025
Q3
$301K Buy
1,068
+82
+8% +$23.8K 0.05% 197
2025
Q2
$275K Sell
986
-9
-0.9% -$2.55K 0.06% 186
2025
Q1
$310K Buy
995
+51
+5% +$15.1K 0.07% 167
2024
Q4
$246K Buy
944
+48
+5% +$14.2K 0.06% 173
2024
Q3
$289K Buy
896
+53
+6% +$17.3K 0.08% 139
2024
Q2
$263K Sell
843
-29
-3% -$8.52K 0.09% 125
2024
Q1
$248K Buy
872
+19
+2% +$5.56K 0.09% 132
2023
Q4
$246K Buy
+853
New +$232K 0.1% 128

Other funds holding AMGN

Apollon Financial's AMGN Position: Q2 2026 in Review

Apollon Financial increased its Amgen (AMGN) stake by 0.5% in Q2 2026, buying an estimated $2.05K and bringing the position to 1,215 shares worth $440K. The position accounts for 0.05% of the portfolio, ranked #218.

Apollon Financial first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Apollon Financial held 1,215 shares of Amgen worth $440K as of Q2 2026.
  • Apollon Financial bought 6 Amgen shares in Q2 2026, an estimated $2.05K.
  • Amgen made up 0.05% of Apollon Financial's portfolio in Q2 2026, its #218 holding.
  • Apollon Financial first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Apollon Financial's 13F filing for Q2 2026, filed 23 Jul 2026.